Skip to content

Tempus AI, Inc. TEM Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

IQVIA logo
IQVIAIQV
$650M-67.3%
Guardant Health logo
Guardant HealthGH
$100.63M
Agilent Technologies logo
Agilent TechnologiesA
$0
Quest Diagnostics logo
Quest DiagnosticsDGX
$0-100%
Danaher logo
DanaherDHR
$0-100%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDebtNetOfIssuanceCosts.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s debt issuance proceeds?
Tempus AI, Inc. (TEM) reported debt issuance proceeds of $0 in Q1 2026.
How has Tempus AI, Inc.'s debt issuance proceeds changed year-over-year?
Tempus AI, Inc.'s debt issuance proceeds decreased by 100.0% year-over-year, from $196M to $0.
What does debt issuance proceeds mean?
Cash received from taking on new debt.
How do you interpret debt issuance proceeds?
Increases suggest aggressive expansion or refinancing, while decreases may indicate limited access to credit or reduced capital needs.
How does debt issuance proceeds compare across companies?
Commonly used by growth companies to fund R&D and infrastructure before reaching profitability.